| Name | 4-hydroxyestrone |
|---|---|
| Synonyms |
4-Hydroxy Estrone
MFCD00079358 (8R,9S,13S,14S)-3,4-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one 4-HydroxyEstrone |
| Description | 4-Hydroxyestrone (4-OHE1), an estrone metabolite, has strong neuroprotective effect against oxidative neurotoxicity. 4-Hydroxyestrone increases cytoplasmic translocation of p53 resulting from SIRT1-mediated deacetylation of p53. 4-Hydroxyestrone has little estrogenic activity[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| References |
| Density | 1.241g/cm3 |
|---|---|
| Boiling Point | 468.2ºC at 760mmHg |
| Melting Point | 260-263ºC |
| Molecular Formula | C18H22O3 |
| Molecular Weight | 286.36500 |
| Flash Point | 251.1ºC |
| Exact Mass | 286.15700 |
| PSA | 57.53000 |
| LogP | 3.52300 |
| Index of Refraction | 1.61 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | KG7749500 |
| Precursor 9 | |
|---|---|
| DownStream 4 | |